Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01397916 · COMPLETED
Trial details
- NCT number
- NCT01397916
- Sponsor
- Tampere University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-12-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.